title: Neuroprotective strategies in Alzheimer's disease.
abstract: In addition to strategies designed to decrease amyloid beta (A beta) levels, it is likely that successful Alzheimer's disease (AD) therapeutic regimens will require the concomitant application of neuroprotective agents. Elucidation of pathophysiological processes occurring in AD and identification of the molecular targets mediating these processes point to potential high-yield neuroprotective strategies. Candidate neuroprotective agents include those that interact specifically with neuronal targets to inhibit deleterious intraneuronal mechanisms triggered by A beta and other toxic stimuli. Strategies include creating small molecules that block A beta interactions with cell surface and intracellular targets, down-regulate stress kinase signaling cascades, block activation of caspases and expression of pro-apoptotic proteins, and inhibit enzymes mediating excessive tau protein phosphorylation. Additional potential neuroprotective compounds include those that counteract loss of cholinergic function, promote the trophic state and plasticity of neurons, inhibit accumulation of reactive oxygen species, and block excitotoxicity. Certain categories of compounds, such as neurotrophins or neurotrophin small molecule mimetics, have the potential to alter neuronal signaling patterns such that several of these target actions might be achieved by a single agent.
authors.affiliation: Department of Neurology, University of North Carolina, Chapel Hill, North Carolina 27599, USA. longof@glial.med.unc.edu
authors.forename: Frank M
authors.initials: FM
authors.lastname: Longo
authors.forename: Stephen M
authors.initials: SM
authors.lastname: Massa
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy / Q000503:physiopathology*; D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000503:physiopathology; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D015398:Signal Transduction / Q000502:physiology*
chemical_list: D018696:Neuroprotective Agents
references.citation: Neurobiol Dis. 1999 Oct;6(5):440-9
references.pmid: 10527810
references.citation: Curr Drug Targets CNS Neurol Disord. 2002 Feb;1(1):31-49
references.pmid: 12769633
references.citation: J Biol Chem. 1993 Nov 5;268(31):22959-62
references.pmid: 8226807
references.citation: Adv Drug Deliv Rev. 2002 Dec 7;54(12):1603-13
references.pmid: 12453677
references.citation: Prog Neurobiol. 1999 Feb;57(4):451-84
references.pmid: 10080385
references.citation: Dement Geriatr Cogn Disord. 1998 Sep-Oct;9(5):246-57
references.pmid: 9701676
references.citation: J Neurosci. 2003 Jul 2;23(13):5531-5
references.pmid: 12843253
references.citation: Biochem J. 2003 May 1;371(Pt 3):789-98
references.pmid: 12534344
references.citation: Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):569-73
references.pmid: 1309947
references.citation: Ann N Y Acad Sci. 1998 Jun 19;845:32-45
references.pmid: 9668341
references.citation: J Neurochem. 1999 Mar;72(3):1327-30
references.pmid: 10037507
references.citation: Eur Neurol. 2000;44(3):172-80
references.pmid: 11053967
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2002 May;26(4):705-12
references.pmid: 12188103
references.citation: Eur J Pharmacol. 2000 Mar 30;393(1-3):255-63
references.pmid: 10771022
references.citation: Curr Opin Neurobiol. 2002 Jun;12(3):260-7
references.pmid: 12049931
references.citation: Neuron. 2003 Mar 27;37(6):889-90
references.pmid: 12670416
references.citation: Trends Neurosci. 2003 Feb;26(2):73-80
references.pmid: 12536130
references.citation: Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10075-8
references.pmid: 1359534
references.citation: Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):12108-13
references.pmid: 10518584
references.citation: Amyloid. 2003 Mar;10(1):1-6
references.pmid: 12762134
references.citation: Cell Mol Neurobiol. 2001 Jun;21(3):173-213
references.pmid: 11569534
references.citation: Neurobiol Aging. 2002 Sep-Oct;23(5):795-807
references.pmid: 12392783
references.citation: Mol Cell Neurosci. 2002 Sep;21(1):15-28
references.pmid: 12359148
references.citation: J Neuropathol Exp Neurol. 2001 Sep;60(9):829-38
references.pmid: 11556539
references.citation: Science. 2002 Jul 19;297(5580):353-6
references.pmid: 12130773
references.citation: Eur J Pharmacol. 1991 Jun 6;198(2-3):215-7
references.pmid: 1864308
references.citation: Nat Rev Neurosci. 2002 Dec;3(12):965-74
references.pmid: 12461553
references.citation: J Mol Neurosci. 2002 Aug-Oct;19(1-2):107-11
references.pmid: 12212765
references.citation: Proc Natl Acad Sci U S A. 1990 Nov;87(22):9020-3
references.pmid: 2174172
references.citation: J Neurochem. 2001 May;77(3):849-63
references.pmid: 11331414
references.citation: Nat Med. 2002 Sep;8(9):936-8
references.pmid: 12205453
references.citation: JAMA. 2002 Jun 26;287(24):3223-9
references.pmid: 12076218
references.citation: J Biol Chem. 2000 Sep 22;275(38):29868-74
references.pmid: 10896671
references.citation: J Neurochem. 2002 Aug;82(3):674-82
references.pmid: 12153491
references.citation: N Engl J Med. 1997 Apr 24;336(17):1216-22
references.pmid: 9110909
references.citation: Bipolar Disord. 2002 Jun;4(3):153-65
references.pmid: 12180271
references.citation: Peptides. 2002 Jul;23(7):1271-83
references.pmid: 12128084
references.citation: JAMA. 2002 Jun 26;287(24):3230-7
references.pmid: 12076219
references.citation: J Neurosci. 2002 Jan 1;22(1):103-13
references.pmid: 11756493
references.citation: Lancet Neurol. 2002 May;1(1):51-7
references.pmid: 12849545
references.citation: Ann Neurol. 2000 Dec;48(6):913-8
references.pmid: 11117548
references.citation: Ann N Y Acad Sci. 2000;924:26-8
references.pmid: 11193797
references.citation: Mol Cell Neurosci. 2001 Aug;18(2):210-20
references.pmid: 11520181
references.citation: Free Radic Res. 2002 Dec;36(12):1307-13
references.pmid: 12607822
references.citation: Trends Pharmacol Sci. 2000 Mar;21(3):93-8
references.pmid: 10689362
references.citation: Prog Neurobiol. 1998 Dec;56(5):541-69
references.pmid: 9775403
references.citation: J Neurosci Res. 2001 Jul 1;65(1):45-53
references.pmid: 11433428
references.citation: Am J Pathol. 2002 Nov;161(5):1869-79
references.pmid: 12414533
references.citation: J Cell Biol. 1996 Dec;135(5):1341-54
references.pmid: 8947555
references.citation: Exp Neurol. 2002 Nov;178(1):104-11
references.pmid: 12460612
references.citation: J Biol Chem. 2001 Apr 27;276(17):13541-6
references.pmid: 11278378
references.citation: Trends Neurosci. 2002 Feb;25(2):79-84
references.pmid: 11814559
references.citation: Trends Neurosci. 2003 Apr;26(4):207-14
references.pmid: 12689772
references.citation: Drug News Perspect. 2002 Nov;15(9):549-557
references.pmid: 12677194
references.citation: Science. 1992 Oct 9;258(5080):304-7
references.pmid: 1411529
references.citation: J Biol Chem. 2002 May 17;277(20):17649-56
references.pmid: 11882652
references.citation: J Comp Neurol. 2000 Mar 13;418(3):241-54
references.pmid: 10701824
references.citation: Science. 2002 Oct 25;298(5594):789-91
references.pmid: 12399581
references.citation: Neurosignals. 2002 Sep-Oct;11(5):236-50
references.pmid: 12566925
references.citation: JAMA. 2002 Jun 26;287(24):3261-3
references.pmid: 12076225
references.citation: Neuroreport. 1995 Oct 2;6(14):1875-9
references.pmid: 8547588
references.citation: J Clin Invest. 2003 Jan;111(1):11-8
references.pmid: 12511580
references.citation: J Alzheimers Dis. 2001 Feb;3(1):41-48
references.pmid: 12214071
references.citation: J Neurosci. 2001 Oct 1;21(19):7551-60
references.pmid: 11567045
references.citation: Am J Public Health. 1998 Sep;88(9):1337-42
references.pmid: 9736873
references.citation: Arch Neurol. 2003 Feb;60(2):203-8
references.pmid: 12580704
references.citation: J Biol Chem. 2002 Jan 25;277(4):2573-8
references.pmid: 11707464
references.citation: Neuron. 2001 Jun;30(3):665-76
references.pmid: 11430801
references.citation: Prog Neurobiol. 2002 Jun;67(3):203-33
references.pmid: 12169297
references.citation: J Mol Neurosci. 2002 Dec;19(3):337-8
references.pmid: 12540061
references.citation: Neuropharmacology. 1993 Dec;32(12):1337-50
references.pmid: 8152525
references.citation: Prog Brain Res. 2000;128:333-47
references.pmid: 11105692
references.citation: Proc Nutr Soc. 2002 May;61(2):191-202
references.pmid: 12133201
references.citation: J Neurovirol. 2002 Dec;8(6):529-38
references.pmid: 12476347
references.citation: Curr Opin Neurobiol. 1996 Oct;6(5):661-6
references.pmid: 8937831
references.citation: Exp Neurol. 2003 Apr;180(2):144-55
references.pmid: 12684028
references.citation: Brain Res Mol Brain Res. 2000 Dec 28;85(1-2):221-33
references.pmid: 11146125
references.citation: J Neurosci. 2002 May 1;22(9):3376-85
references.pmid: 11978814
references.citation: Arch Neurol. 2002 Jun;59(6):972-6
references.pmid: 12056933
references.citation: J Biol Chem. 2002 Nov 1;277(44):42060-5
references.pmid: 12191990
references.citation: J Mol Neurosci. 2002 Aug-Oct;19(1-2):101-5
references.pmid: 12212764
references.citation: Biochem Pharmacol. 2002 Feb 15;63(4):563-7
references.pmid: 11992623
references.citation: J Mol Neurosci. 2002 Dec;19(3):303-7
references.pmid: 12540056
references.citation: J Mol Neurosci. 2000 Feb-Apr;14(1-2):61-8
references.pmid: 10854037
references.citation: Annu Rev Pharmacol Toxicol. 2003;43:545-84
references.pmid: 12415125
references.citation: Restor Neurol Neurosci. 1998;13(1-2):75-83
references.pmid: 12671289
references.citation: J Biol Chem. 2003 Jul 25;278(30):28294-302
references.pmid: 12730216
references.citation: Annu Rev Neurosci. 2001;24:1217-81
references.pmid: 11520933
references.citation: Cytokine Growth Factor Rev. 2003 Jun-Aug;14(3-4):225-39
references.pmid: 12787561
references.citation: Brain Res. 2002 Dec 20;958(1):210-21
references.pmid: 12468047
references.citation: Eur Neurol. 2000;44(4):236-41
references.pmid: 11096224
references.citation: Prog Neurobiol. 2002 Oct;68(3):209-45
references.pmid: 12450488
references.citation: Med Clin North Am. 2002 May;86(3):615-27
references.pmid: 12168561
references.citation: Arch Neurol. 2003 Jun;60(6):843-8
references.pmid: 12810489
references.citation: N Engl J Med. 2003 Apr 3;348(14):1333-41
references.pmid: 12672860
references.citation: Brain Res. 1993 Sep 3;621(1):35-49
references.pmid: 8221072
references.citation: J Neurosci. 1999 Sep 15;19(18):8009-26
references.pmid: 10479701
references.citation: Ann N Y Acad Sci. 1994 Dec 15;747:162-71
references.pmid: 7847669
references.citation: Nat Rev Neurosci. 2003 Apr;4(4):299-309
references.pmid: 12671646
references.citation: Free Radic Biol Med. 2002 Nov 1;33(9):1194-9
references.pmid: 12398927
references.citation: J Mol Neurosci. 2002 Aug-Oct;19(1-2):145-53
references.pmid: 12212772
references.citation: J Neurosci. 2001 Nov 1;21(21):8370-7
references.pmid: 11606625
references.citation: CNS Drugs. 2003;17(9):641-52
references.pmid: 12828500
references.citation: Nature. 2000 Oct 12;407(6805):802-9
references.pmid: 11048732
references.citation: J Cell Biol. 2002 Feb 4;156(3):519-29
references.pmid: 11815632
references.citation: J Neurosci Res. 2002 Nov 1;70(3):380-91
references.pmid: 12391601
references.citation: Eur J Neurosci. 1994 Apr 1;6(4):668-71
references.pmid: 8025717
references.citation: Biol Psychiatry. 2001 Feb 1;49(3):289-99
references.pmid: 11230880
references.citation: J Neurochem. 2001 Apr;77(1):157-64
references.pmid: 11279271
references.citation: J Neurochem. 2001 Jan;76(2):435-41
references.pmid: 11208906
references.citation: Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10439-44
references.pmid: 11504920
references.citation: Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4772-7
references.pmid: 9114067
references.citation: Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):4086-91
references.pmid: 9108109
references.citation: J Neurosci Res. 1997 Apr 1;48(1):1-17
references.pmid: 9086177
references.citation: Exp Neurol. 2002 Nov;178(1):91-103
references.pmid: 12460611